Zacks Research Has Bullish Forecast for TSE:BHC Q2 Earnings

Bausch Health Companies Inc. (TSE:BHC) – Investment analysts at Zacks Research upped their Q2 2026 earnings per share (EPS) estimates for shares of Bausch Health Companies in a research note issued on Tuesday, May 19th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $1.31 for the quarter, up from their previous forecast of $1.28. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q3 2026 earnings at $1.42 EPS, Q4 2026 earnings at $1.58 EPS, Q1 2027 earnings at $1.12 EPS, Q2 2027 earnings at $1.13 EPS, Q4 2027 earnings at $1.30 EPS, FY2027 earnings at $4.97 EPS, Q1 2028 earnings at $0.82 EPS and FY2028 earnings at $4.24 EPS.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 earnings per share for the quarter. The business had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%.

Bausch Health Companies Price Performance

Shares of Bausch Health Companies stock opened at C$7.33 on Wednesday. The stock has a market cap of C$2.74 billion, a price-to-earnings ratio of -2.26, a price-to-earnings-growth ratio of 0.21 and a beta of 0.63. The company has a debt-to-equity ratio of -1,009.96, a quick ratio of 0.58 and a current ratio of 1.32. The stock has a 50 day moving average price of C$7.45 and a 200-day moving average price of C$8.47. Bausch Health Companies has a one year low of C$6.06 and a one year high of C$11.97.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.